1 Rose JW Watt HE White AT Carlson NG . Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann Neurol2004; 56: 864–867.
2.
2 Smith MD Downie JB DiCostanzo D . Granuloma annulare. Int J Dermatol1997; 36: 326–333.
3.
3 Umbert P Winkelmann RK . Histologic, ultrastructural and histochemical studies of granuloma annulare. Arch Dermatol1977; 113: 1681–1686.
4.
4 Buechner SA Winkelmann RK Banks PM . Identification of T-cell subpopulations in granuloma annulare. Arch Dermatol1983; 119: 125–128.
5.
5 Modlin RL Horwitz DA Jordan RR Gebhard JF Taylor CR Rea TH . Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare. Pediatr Dermatol1984; 2: 26–32.
6.
6 Mempel M Musette P Flageul B . T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation. J Invest Dermatol2002; 118: 957–966.
7.
7 Serarslan G Okuyucu EE Melek IM Hakverdi S Duman T . Widerspread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis. Mult Scler2008; 14: 259–261.
